Business Description
Angion Biomedica Corp
NAICS : 325412
SIC : 2834
Share Class Description:
FRA:5YX: Ordinary SharesCompare
Compare
Traded in other countries / regions
5YX.GermanyANGN.USA IPO Date
2021-10-27Description
Angion Biomedica Corp is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Its product candidate, ANG-3777, is a hepatocyte growth factor (HGF) mimetic that is evaluating in multiple acute organ injuries and related indications, including acute kidney injury (AKI) and injuries to other major organs, such as the lungs, central nervous system (CNS) and heart; acute lung injury (ALI), with a primary focus on acute respiratory distress syndrome (ARDS), and acute CNS injuries. It is advancing multiple programs for the treatment of fibrotic diseases, leading to ANG-3070, a tyrosine kinase inhibitor (TKI), and inhibitor of rho kinase 2 (ROCK2).
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 96.97 | |||||
| 6-1 Month Momentum % | -16.25 | |||||
| 12-1 Month Momentum % | -58.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -4787.06 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Angion Biomedica Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.618 | ||
| EPS (TTM) (€) | -0.925 | ||
| Beta | 0 | ||
| Volatility % | 76.45 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.257143 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | -58.39 | ||
| 52-Week Range (€) | 6 - 17.1 | ||
| Shares Outstanding (Mil) | 30.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Angion Biomedica Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Angion Biomedica Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Angion Biomedica Corp Frequently Asked Questions
What is Angion Biomedica Corp(FRA:5YX)'s stock price today?
The current price of FRA:5YX is €9.05. The 52 week high of FRA:5YX is €17.10 and 52 week low is €6.00.
When is next earnings date of Angion Biomedica Corp(FRA:5YX)?
The next earnings date of Angion Biomedica Corp(FRA:5YX) is .
Does Angion Biomedica Corp(FRA:5YX) pay dividends? If so, how much?
Angion Biomedica Corp(FRA:5YX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers